Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES Plunges 4%; BSE HEALTHCARE Index Down 0.8%
Wed, 23 Oct 16:45

ALKEM LABORATORIES Plunges 4%; BSE HEALTHCARE Index Down 0.8%Image source: KanawatTH/www.istockphoto.com

ALKEM LABORATORIES share price has plunged 4% and is presently trading at Rs 5,857.5.

Meanwhile, the BSE HEALTHCARE index is at 42,709.7 (down 0.8%).

Among the top losers in the BSE HEALTHCARE index today are Sun Pharma (down 2.8%) and Lupin (down 2.6%).

GSK Pharma (up 2.3%) and GRANULES INDIA (up 2.0%) are among the top gainers today.

Over the last one year, ALKEM LABORATORIES has moved up from Rs 3,531.8 to Rs 5,857.5, registering a gain of Rs 2,325.7 (up 65.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,709.7, registering a gain of 55.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 215.1%), Glenmark Pharma (up 122.7%) and SUVEN PHARMACEUTICALS (up 119.9%).

Don't Miss: Key Information for Long-term Investors

What About the Benchmark Indices?

The BSE Sensex is at 80,082.0 (down 0.2%).

The top losers among the BSE Sensex today are M&M (down 3.0%) and Sun Pharma (down 2.8%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,436.0 (down 0.2%). M&M and Sun Pharma are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,082.0, registering a gain of 15,510.1 points (up 24.0%).

ALKEM LABORATORIES Financial Update...

ALKEM LABORATORIES net profit grew 91.2% YoY to Rs 5,502 million for the quarter ended June 2024, compared to a profit of Rs 2,878 million a year ago. Net sales rose 2.2% to Rs 30,318 million during the period as against Rs 29,677 million in April-June 2023.

For the year ended March 2024, ALKEM LABORATORIES reported 79.9% increase in net profit to Rs 18,115 million compared to net profit of Rs 10,068 million during FY23. Revenue of the company grew 9.2% to Rs 126,676 million during FY24.

The current Price to earnings ratio of ALKEM LABORATORIES, based on rolling 12 month earnings, stands at 33.8.


Equitymaster requests your view! Post a comment on "ALKEM LABORATORIES Plunges 4%; BSE HEALTHCARE Index Down 0.8%". Click here!